A service of arranging or bringing about contact between an investment manager and an issuer or potential issuer.
This company webcast features Cerrado Gold (TSXV: CERT / OTCQX: CRDOF). Cerrado is a Toronto-based gold production, development, and exploration company focused on gold projects in South America. This company webcast was recorded during the Lytham Partners 2025...
This company webcast features NeurAxis, Inc. (NYSE American: NRXS). NeurAxis is a medical technology company focused on neuromodulation therapies to address chronic and debilitating conditions in children and adults. This company webcast was recorded during the Lytham...
This company webcast features Quipt Home Medical (Nasdaq: QIPT / TSX: QIPT). Quipt provides in-home monitoring and disease management services including end-to-end respiratory solutions for patients in the United States healthcare market. This company webcast was...
This company webcast features PolyPid Ltd. (Nasdaq: PYPD). PolyPid is a late-stage biopharma company aiming to improve surgical outcomes. This company webcast was recorded during the Lytham Partners 2025 Investor Healthcare Summit.
This company webcast features Reviva Pharmaceuticals Holdings (Nasdaq: RVPH). Reviva is a late-stage biopharmaceutical company that discovers, develops, and seeks to commercialize next-generation therapeutics for diseases representing unmet medical needs and burdens...
This company webcast features ChromaDex Corp. (Nasdaq: CDXC). ChromaDex is the global authority on nicotinamide adenine dinucleotide (NAD+), with a focus on the science of healthy aging. This company webcast was recorded during the Lytham Partners 2025 Investor...
This company webcast features Cybin, Inc. (NYSE American: CYBN). Cybin is a late-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options to address the large unmet...
This company webcast features Beyond Air (Nasdaq: XAIR). Beyond Air is a commercial stage medical device and biopharmaceutical company dedicated to harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from...
This company webcast features Kairos Pharma (NYSE American: KAPA). Kairos Pharma is at the forefront of oncology therapeutics, utilizing structural biology to overcome drug resistance and immune suppression in cancer. This company webcast was recorded during the...
This company webcast features Genvara BioPharma. Genvara Biopharma's mission is to develop pharmacogenetically-targeted cardiovascular drugs acting through novel mechanisms of action. This company webcast was recorded during the Lytham Partners 2025 Investor...